GlobeNewswire Inc.··Rosen Law FirmDisc Medicine Stock Plummets 22% After FDA Rejects Bitopertin Program
Disc Medicine ($IRON) stock fell 22% after FDA rejected bitopertin program, triggering class action lawsuit investigation by Rosen Law Firm.
IRONsecurities fraudclass action lawsuit